BioLattice Ophthalmics, Inc,
Biotechnology · Philadelphia, PA, United States
- CompanyBioLattice Ophthalmics, Inc,Philadelphia, PA, United States
- Phone line+1 (267) 481-5423General business
BioLattice Ophthalmics, Inc, is a privately held biotechnology company based in Philadelphia, PA that filed a Form D exempt offering notice with the SEC on 30-MAR-2026.
Capabilities
Pharmaceutical manufacturing
Evidence for each capability
- Pharmaceutical manufacturing. Form D industry group: Biotechnology — SEC Form D data sets (private offerings)
People 3
Chair & board
Gregory JacksonDirector
Everyone else on file (2)
Amelia ZellanderExecutive Officer, Director
Linda AlunkalExecutive Officer, Director
Source timeline
Record created from SEC Form D data sets (private offerings)
SEC Form D data sets (private offerings) ↗Amelia Zellander — Executive Officer, Director
SEC Form D data sets (private offerings) ↗Linda Alunkal — Executive Officer, Director
SEC Form D data sets (private offerings) ↗Gregory Jackson — Director
SEC Form D data sets (private offerings) ↗
Similar makers
IceCure Medical Ltd.Biotechnology · Caesarea1 shared capabilityPluri Inc.Biological Products, (No Diagnostic Substances) · Haifa1 shared capabilityEntera Bio Ltd.Biological Products, (No Diagnostic Substances) · Jerusalem1 shared capabilityAdaptimmune Therapeutics PLCBiological Products, (No Diagnostic Substances) · Abingdon, Oxfordshire1 shared capabilityDBV Technologies S.A.Biological Products, (No Diagnostic Substances) · Chatillon1 shared capabilityBeOne Medicines Ltd.Pharmaceutical Preparations · Basel1 shared capabilityZai Lab LtdPharmaceutical Preparations · Shanghai1 shared capabilityenGene Therapeutics Inc.Biological Products, (No Diagnostic Substances) · Saint-Laurent1 shared capability